136 related articles for article (PubMed ID: 37736544)
1. Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II.
Yang TM; Singla N; Chen CH; Hsieh JT; Yeh HC
Front Oncol; 2023; 13():1276718. PubMed ID: 37736544
[No Abstract] [Full Text] [Related]
2. Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma.
Sheu ZL; Singla N; Chen CH; Hsieh JT; Yeh HC
Front Oncol; 2022; 12():956352. PubMed ID: 35800048
[No Abstract] [Full Text] [Related]
3. Impact of Surgical Wait Time on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma With Hydronephrosis.
Zhao F; Qi N; Zhang C; Xue N; Li S; Zhou R; Chen Z; Yao R; Zhu H
Front Oncol; 2021; 11():698594. PubMed ID: 34290988
[TBL] [Abstract][Full Text] [Related]
4. Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma.
Tsuzuki S; Kimura S; Fukuokaya W; Yanagisawa T; Hata K; Miki J; Kimura T; Abe H; Egawa S
Jpn J Clin Oncol; 2021 Jan; 51(1):138-144. PubMed ID: 32728722
[TBL] [Abstract][Full Text] [Related]
5. Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?
Lai S; Wu P; Diao T; Seery S; Liu J; Hou H; Liu M; Wang J
Jpn J Clin Oncol; 2021 Mar; 51(3):469-477. PubMed ID: 32734304
[TBL] [Abstract][Full Text] [Related]
6. The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma.
Zhang X; Wang P; Qi K; Qiao Q; Jiang Y
Cancer Med; 2021 Nov; 10(22):8079-8090. PubMed ID: 34647688
[TBL] [Abstract][Full Text] [Related]
7. Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma.
Lee JN; Kwon SY; Choi GS; Kim HT; Kim TH; Kwon TG; Kim BW
J Surg Oncol; 2014 Sep; 110(4):468-75. PubMed ID: 25059848
[TBL] [Abstract][Full Text] [Related]
8. Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study.
Almås B; Øverby S; Halvorsen OJ; Reisæter LAR; Assmus J; Carlsen B; Loe A; Beisland C
World J Urol; 2020 Mar; 38(3):717-723. PubMed ID: 31123851
[TBL] [Abstract][Full Text] [Related]
9. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
Rouprêt M; Hupertan V; Seisen T; Colin P; Xylinas E; Yates DR; Fajkovic H; Lotan Y; Raman JD; Zigeuner R; Remzi M; Bolenz C; Novara G; Kassouf W; Ouzzane A; Rozet F; Cussenot O; Martinez-Salamanca JI; Fritsche HM; Walton TJ; Wood CG; Bensalah K; Karakiewicz PI; Montorsi F; Margulis V; Shariat SF; ;
J Urol; 2013 May; 189(5):1662-9. PubMed ID: 23103802
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma.
Krabbe LM; Eminaga O; Shariat SF; Hutchinson RC; Lotan Y; Sagalowsky AI; Raman JD; Wood CG; Weizer AZ; Roscigno M; Montorsi F; Bolenz C; Novara G; Kikuchi E; Fajkovic H; Rapoport LM; Glybochko PV; Zigeuner R; Remzi M; Bensalah K; Kassouf W; Margulis V
J Urol; 2017 Mar; 197(3 Pt 1):580-589. PubMed ID: 27670916
[TBL] [Abstract][Full Text] [Related]
11. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
[TBL] [Abstract][Full Text] [Related]
12. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
[TBL] [Abstract][Full Text] [Related]
13. Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison.
Sanford T; Porten S; Meng MV
PLoS One; 2015; 10(8):e0137141. PubMed ID: 26317352
[TBL] [Abstract][Full Text] [Related]
14. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
Margulis V; Youssef RF; Karakiewicz PI; Lotan Y; Wood CG; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Shariat SF;
J Urol; 2010 Aug; 184(2):453-8. PubMed ID: 20620397
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma.
Hou G; Zheng Y; Zhang L; Lai D; Wang F; Li X; Yan F; Tian J; Zhang G; Meng P; Wei D; Zhu Z; Yuan J; Hui Q; Yuan J
World J Urol; 2020 Aug; 38(8):1969-1975. PubMed ID: 31654221
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of upper tract urothelial carcinoma.
Bird VG; Kanagarajah P
Indian J Urol; 2011 Jan; 27(1):2-9. PubMed ID: 21716884
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of fatty acid synthase expression in upper urinary tract urothelial carcinoma.
Hamada S; Horiguchi A; Asano T; Kuroda K; Asakuma J; Ito K; Asano T; Miyai K; Iwaya K
Jpn J Clin Oncol; 2014 May; 44(5):486-92. PubMed ID: 24643292
[TBL] [Abstract][Full Text] [Related]
18. Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning.
Liu J; Wu P; Lai S; Wang J; Hou H; Zhang Y
BMC Cancer; 2023 Jun; 23(1):574. PubMed ID: 37349696
[TBL] [Abstract][Full Text] [Related]
19. Sustained complete response to first-line immunochemotherapy for highly aggressive TP53/MDM2-mutated upper tract urothelial carcinoma with ERBB2 mutations, luminal immune-infiltrated contexture, and non-mesenchymal state: a case report and literature review.
Xu T; Guo H; Xie J; He Y; Che J; Peng B; Yang B; Yao X
Front Oncol; 2023; 13():1119343. PubMed ID: 37427135
[TBL] [Abstract][Full Text] [Related]
20. BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.
Yamamoto Y; Oga A; Akao J; Misumi T; Fuji N; Kobayashi K; Kawai Y; Inoue R; Hirata H; Matsumoto H; Nagao K; Sakano S; Matsuyama H
Jpn J Clin Oncol; 2016 Aug; 46(8):754-61. PubMed ID: 27174960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
